StockGlow

Humacyte, Inc. (HUMAW)

Humacyte, Inc., engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas.

$0.01-0.11%
Compare HUMAW with
StockGlow Score
50
Neutral
BearishBullish
1 year ago-92.7%

The outlook

Analyst and trend data are thin for HUMAW right now, so there isn't enough to form a clear read. Check back later as coverage updates.

What’s behind the score

Analyst and trend data are thin for this ticker right now.

Market cap
—
52-wk high
$0.01
52-wk low
$0.01
50-day avg
—
200-day avg
—
Trailing P/E
—

Similar stocks

CELUWCelularity Inc.$0.00+533.33%JSPRWJasper Therapeutics, Inc.$0.01+0.00%SRZNWSurrozen, Inc.$0.01+0.00%HUMAHumacyte, Inc.$0.66-1.76%SABSWSAB Biotherapeutics, Inc.$0.02+37.76%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy